0S90 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Syros Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.0885 EUR -1.12% Market Closed

Market Cap: €2.4m

	Syros Pharmaceuticals Inc F:0S90	US
H	Hess Corp XMUN:AHC	US
	DSV A/S OTC:DSDVF	DK
L	Lincoln National Corp XMUN:LCO	US
E	Equity Residential F:EQR	US
A	AGNC Investment Corp LSE:0H6E	US
	Miramar Hotel and Investment Co Ltd HKEX:71	HK
R	Relx PLC XETRA:RDEB	UK
	Mo-Bruk SA OTC:MBRFF	PL
	Imugene Ltd ASX:IMUDA	AU
C	Chorus Ltd ASX:CNU	NZ
A	American International Group Inc XMUN:AINN	US
W	WesBanco Inc F:WEY	US
D	Datang International Power Generation Co Ltd XMUN:BJI	CN

Profitability Summary

Syros Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-28 892%

Negative 3Y Average Operating Margin

-6 337%

Declining Operating Margin

-1 151% > -28 892%

Negative Net Margin

-25 341%

Negative 3Y Average Net Margin

-5 750%

Declining Net Margin

-754% > -25 341%

Negative Free Cash Flow Margin

-25 910%

Negative 3Y Average Free Cash Flow Margin

-5 670%

Declining Free Cash Flow Margin

-1 061% > -25 910%

Negative ROE

-777%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-464%

Declining ROIC

-376% > -448%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.